ロード中...
Radiotherapy and CTLA-4 blockade shape the TCR repertoire of tumor-infiltrating T cells
Immune checkpoint inhibitors activate T cells to reject tumors. Unique tumor mutations are key T-cell targets, but a comprehensive understanding of the nature of a successful antitumor T-cell response is lacking. To investigate the T-cell receptor (TCR) repertoire associated with treatment success v...
保存先:
| 出版年: | Cancer Immunol Res |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6020019/ https://ncbi.nlm.nih.gov/pubmed/29180535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-17-0134 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|